Publications by authors named "E S Lapadula"
Introduction: The GENCOV study sought to evaluate serological differences between individuals with differing COVID-19 severity and outcomes. We assessed the SARS-CoV-2 antibody response of GENCOV participants cross-sectionally 1-, 6-, and 12-months following COVID-19 diagnosis to identify patient factors associated with more robust and durable humoral immune responses.
Materials And Methods: COVID-19 patients and a control cohort of vaccinated infection-naïve participants were recruited at hospital sites across the Greater Toronto Area in Ontario, Canada.
Article Synopsis
- Novel genome sequencing (GS) presents new chances to share results with healthy people, leading to a need for effective genetic counseling methods.
- A study with 466 participants used a genomic counseling model (GCM) that included a digital platform and webinars, showing that knowledge about genetics improved and decisional conflict (uncertainty in decision-making) decreased after the counseling.
- Most participants (86%) wanted to learn all GS findings after the counseling, indicating that the GCM effectively informed the general public and helped them feel more confident in decisions about genetic information.
The Editorial Office retracts the article, "Sex-Based Differences in Plasma Autoantibodies to Central Nervous System Proteins in Gulf War Veterans versus Healthy and Symptomatic Controls" [...
View Article and Find Full Text PDFArticle Synopsis
- The Editorial Office has decided to retract the article titled "Using Plasma Autoantibodies of Central Nervous System Proteins to Distinguish Veterans with Gulf War Illness from Healthy and Symptomatic Controls."
- This retraction indicates that there were likely significant issues or concerns regarding the validity or integrity of the research presented in the article.
- Such actions are typically taken to maintain the credibility of scientific literature and ensure that published findings are reliable and accurate.
Background: GENCOV is a prospective, observational cohort study of COVID-19-positive adults. Here, we characterize and compare side effects between COVID-19 vaccines and determine whether reactogenicity is exacerbated by prior SARS-CoV-2 infection.
Methods: Participants were recruited across Ontario, Canada.